Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VRC01 with cART in HIV-1 Infected Infants
NCT03208231Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Aug 2018
- Primary completion
- Jun 2020
- Modality
- Anti-infectious Disease mAbs
- Countries
- 4
01
Overview
A Phase 2 trial of VRC01 in human immunodeficiency virus type 1 infection (HIV-1), sponsored by National Institute of Allergy and Infectious Diseases. Started Aug 2018; status: completed.
02
Drugs
VRC01
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT03208231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03208231.